Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Healthtrust
Merck
Julphar
Harvard Business School
Fuji
Express Scripts
Argus Health
AstraZeneca

Generated: February 18, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin ethylsuccinate; sulfisoxazole acetyl and what is the scope of erythromycin ethylsuccinate; sulfisoxazole acetyl patent protection?

Erythromycin ethylsuccinate; sulfisoxazole acetyl
is the generic ingredient in three branded drugs marketed by Barr, Alra, and Ross Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for erythromycin ethylsuccinate; sulfisoxazole acetyl. Two suppliers are listed for this compound.
Summary for ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
Pharmacology for ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

US Patents and Regulatory Information for ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062759-001 May 20, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alra ERYZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062758-001 Jun 15, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ross Labs PEDIAZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 050529-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Daiichi Sankyo
Argus Health
UBS
Federal Trade Commission
Chubb
McKinsey
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot